Currently there is no description available for Niko Lusiani.
“Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that's still a drop in the bucket compared to the need across the world. We need a transformation towards more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints.”
10 Jun 2021
2
3
Read More
